scPharmaceuticals Inc.

NASDAQ:SCPH

3.38 (USD) • At close January 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Revenue 10.0268.0546.1026.0963.7961.6382.0630000000000000000000000000000
Cost of Revenue 3.3112.31.8361.7731.0790.3540.6050.120.1180.1280.1020.1110.1120.1090.10600000000000000000000
Gross Profit 6.7155.7544.2664.3232.7171.2841.458-0.12-0.118-0.128-0.102-0.111-0.112-0.109-0.10600000000000000000000
Gross Profit Ratio 0.670.7140.6990.7090.7160.7840.7070000000000000000000000000000
Reseach & Development Expenses 3.5412.6772.7263.3383.4212.9342.1162.3263.7185.1424.3474.533.6943.8074.0093.7455.1195.1394.1468.3184.2935.4966.5243.1493.8964.8554.0483.7163.5854.1452.8853.0173.6172.6112.611
General & Administrative Expenses 001.07522.992012.09610.8967.1766.2774.2792.8932.1912.2112.6492.7323.4253.3192.5372.5032.1151.9961.8392.3232.0741.9455.0494.6512.9921.6652.3742.0740.9432.161.4761.476
Selling & Marketing Expenses 0016.321-6.750000000000000000000000000000000
SG&A 21.3217.50817.39616.24214.13512.09610.8967.1766.2774.2792.8932.1912.2112.6492.7323.4253.3192.5372.5032.1151.9961.8392.3232.0741.9455.0494.6512.9921.6652.3742.0740.9432.161.4761.476
Other Expenses 002.9722.412-0.0360.2390.991.363-0.0220.0640.0140.0170.010.0330.2550.0090.019-0.001-0.031-0.0450.083-0.014-0.0080.002-0.005-0.011-0.042-0.0070.0150.0570.010.027000
Operating Expenses 24.86120.18520.12219.5817.55615.0313.0129.5029.9959.4217.246.7215.9056.4566.7417.178.4387.6766.64910.4336.2897.3358.8475.2235.8419.9048.6996.7085.256.5194.9593.965.7834.0784.078
Operating Income -18.146-14.431-15.856-15.257-14.839-13.746-11.554-9.502-9.995-9.421-7.24-6.721-5.905-6.456-6.741-7.17-8.438-7.676-6.649-10.433-6.289-7.335-8.847-5.223-5.841-9.904-8.699-6.708-5.25-6.519-4.959-3.96-5.777-4.087-4.087
Operating Income Ratio -1.81-1.792-2.598-2.503-3.909-8.392-5.6010000000000000000000000000000
Total Other Income Expenses Net -16.959-2.6591.7481.445-0.795-0.4080.3440.254-0.167-0.276-0.491-0.597-0.647-0.606-0.361-0.614-0.6-0.619-0.443-0.3810.0820.080.1280.1230.080.054-0.033-0.172-0.239-0.0170.047-1.358-3.307-0.901-0.901
Income Before Tax -35.105-17.09-14.108-13.812-15.634-14.154-11.21-9.248-10.162-9.697-7.731-7.318-6.552-7.062-7.102-7.784-9.038-8.295-7.092-10.814-6.207-7.255-8.719-5.1-5.761-9.85-8.732-6.88-5.489-6.536-4.912-5.318-9.084-4.988-4.988
Income Before Tax Ratio -3.501-2.122-2.312-2.266-4.119-8.641-5.4340000000000000000000000000000
Income Tax Expense 000.008-3.485-0.2722.141.6170.5140.1670.2760.4910.5970.6470.6060.3610.6140.60.6190.4430.381-0.082-0.08-0.128-0.123-0.08-0.0540.0330.1720.2390.017-0.0471.358000
Net Income -35.105-17.09-14.108-13.812-15.634-14.154-12.827-9.762-10.329-9.973-8.222-7.318-6.552-7.062-7.102-7.784-9.038-8.295-7.092-10.814-6.207-7.255-8.719-5.1-5.761-9.85-8.732-6.88-5.489-6.536-4.912-5.318-9.084-4.988-4.988
Net Income Ratio -3.501-2.122-2.312-2.266-4.119-8.641-6.2180000000000000000000000000000
EPS -0.75-0.44-0.36-0.36-0.4-0.37-0.34-0.31-0.38-0.36-0.3-0.27-0.24-0.26-0.26-0.28-0.33-0.36-0.35-0.58-0.33-0.39-0.47-0.27-0.31-0.53-0.47-0.8-0.31-0.58-0.44-0.47-8.52-5.65-5.65
EPS Diluted -0.75-0.44-0.36-0.36-0.4-0.37-0.34-0.31-0.38-0.36-0.3-0.27-0.24-0.26-0.26-0.28-0.33-0.36-0.35-0.58-0.33-0.39-0.47-0.27-0.31-0.53-0.47-0.8-0.31-0.58-0.44-0.47-8.52-5.65-5.65
EBITDA -33.25-14.904-11.956-11.58-13.302-12.035-9.144-7.169-9.667-9.122-7.111-6.586-5.773-6.302-6.36-7.023-8.282-7.557-6.361-10.074-5.717-6.796-8.276-4.645-5.317-9.409-8.309-6.535-5.155-6.378-4.886-3.927-5.776-4.085-4.085
EBITDA Ratio -3.316-1.851-2.59-2.48-3.909-7.414-4.4830000000000000000000000000000